Advertisement

Optimizing the Laboratory Diagnosis of Clostridium difficile Infection

  • Peter H. Gilligan
    Correspondence
    Pathology-Laboratory Medicine, UNC School of Medicine, CB 7600, Chapel Hill, NC 27516.
    Affiliations
    Clinical Microbiology-Immunology Laboratories, Microbiology-Immunology, UNC Health Care, UNC School of Medicine, CB 7600, Chapel Hill, NC 27516, USA

    Pathology-Laboratory Medicine, UNC School of Medicine, CB 7600, Chapel Hill, NC 27516, USA
    Search for articles by this author
Published:March 19, 2015DOI:https://doi.org/10.1016/j.cll.2015.02.003

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Magill S.S.
        • Edwards J.R.
        • Bamberg W.
        • et al.
        Multistate point-prevalence survey of health care-associated infections.
        N Engl J Med. 2014; 370: 1198-1208
        • Peery A.F.
        • Dellon E.S.
        • Lund J.
        • et al.
        Burden of gastrointestinal disease in the United States: 2012 update.
        Gastroenterology. 2012; 143: 1179-1187.e1–3
        • Lessa F.C.
        • Gould C.V.
        • McDonald L.C.
        Current status of Clostridium difficile infection epidemiology.
        Clin Infect Dis. 2012; 55: S65-S70
        • Walker A.S.
        • Eyre D.W.
        • Wyllie D.H.
        • et al.
        Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection.
        Clin Infect Dis. 2013; 56: 1589-1600
        • Burnham C.A.
        • Carroll K.C.
        Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.
        Clin Microbiol Rev. 2013; 26: 604-630
        • Bartlett J.G.
        • Moon N.
        • Chang T.W.
        • et al.
        Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis.
        Gastroenterology. 1978; 75: 778-782
        • Surawicz C.M.
        • Brandt L.J.
        • Binion D.G.
        • et al.
        Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections.
        Am J Gastroenterol. 2013; 108 ([quiz: 99]): 478-498
        • Taur Y.
        • Pamer E.G.
        Harnessing microbiota to kill a pathogen: fixing the microbiota to treat Clostridium difficile infections.
        Nat Med. 2014; 20: 246-247
        • Schubert A.M.
        • Rogers M.A.
        • Ring C.
        • et al.
        Microbiome data distinguish patients with Clostridium difficile infection and non-C. difficile-associated diarrhea from healthy controls.
        MBio. 2014; 5 (e01021–14)
        • Petrof E.O.
        • Gloor G.B.
        • Vanner S.J.
        • et al.
        Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut.
        Microbiome. 2013; 1: 3
        • Youngster I.
        • Russell G.H.
        • Pindar C.
        • et al.
        Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection.
        JAMA. 2014; 312: 1772-1778
        • van Nood E.
        • Vrieze A.
        • Nieuwdorp M.
        • et al.
        Duodenal infusion of donor feces for recurrent Clostridium difficile.
        N Engl J Med. 2013; 368: 407-415
        • Kassam Z.
        • Lee C.H.
        • Yuan Y.
        • et al.
        Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis.
        Am J Gastroenterol. 2013; 108: 500-508
        • Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infections
        Updated guidance on the diagnosis and reporting of Clostridium difficile.
        National Health Service, United Kingdom2012
        • Gilligan P.
        Contemporary approaches for the laboratory diagnosis of Clostridium difficile infections.
        Semin Colon Rectal Surg. 2014; 25: 137-142
        • Kutty P.K.
        • Woods C.W.
        • Sena A.C.
        • et al.
        Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA.
        Emerg Infect Dis. 2010; 16: 197-204
        • McCarthy K.
        • Johnston S.
        • Hepworth C.
        Clostridium difficile-associated colitis following the use of Chinese medicine.
        BMJ Case Rep. 2009; 2009https://doi.org/10.1136/bcr.08.2008.0716
        • Dubberke E.R.
        • Han Z.
        • Bobo L.
        • et al.
        Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections.
        J Clin Microbiol. 2011; 49: 2887-2893
        • Caroff D.A.
        • Edelstein P.H.
        • Hamilton K.
        • et al.
        The Bristol Stool Scale and its relationship to Clostridium difficile infection.
        J Clin Microbiol. 2014; 52: 3437-3439
        • Brecher S.M.
        • Novak-Weekley S.M.
        • Nagy E.
        Laboratory diagnosis of Clostridium difficile infections: there is light at the end of the colon.
        Clin Infect Dis. 2013; 57: 1175-1181
        • Schutze G.E.
        • Willoughby R.E.
        Clostridium difficile infection in infants and children.
        Pediatrics. 2013; 131: 196-200
        • Viscidi R.
        • Willey S.
        • Bartlett J.G.
        Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations.
        Gastroenterology. 1981; 81: 5-9
        • Galdys A.L.
        • Nelson J.S.
        • Shutt K.A.
        • et al.
        Prevalence and duration of asymptomatic Clostridium difficile carriage among healthy subjects in Pittsburgh, Pennsylvania.
        J Clin Microbiol. 2014; 52: 2406-2409
        • Guerrero D.M.
        • Becker J.C.
        • Eckstein E.C.
        • et al.
        Asymptomatic carriage of toxigenic Clostridium difficile by hospitalized patients.
        J Hosp Infect. 2013; 85: 155-158
        • Alasmari F.
        • Seiler S.M.
        • Hink T.
        • et al.
        Prevalence and risk factors for asymptomatic Clostridium difficile carriage.
        Clin Infect Dis. 2014; 59: 216-222
        • Koo H.L.
        • Van J.N.
        • Zhao M.
        • et al.
        Real-time polymerase chain reaction detection of asymptomatic Clostridium difficile colonization and rising C. difficile-associated disease rates.
        Infect Control Hosp Epidemiol. 2014; 35: 667-673
        • Willems L.
        • Porcher R.
        • Lafaurie M.
        • et al.
        Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.
        Biol Blood Marrow Transplantant. 2012; 18: 1295-1301
        • Khanna S.
        • Pardi D.S.
        • Rosenblatt J.E.
        • et al.
        An evaluation of repeat stool testing for Clostridium difficile infection by polymerase chain reaction.
        J Clin Gastroenterol. 2012; 46: 846-849
        • Nistico J.A.
        • Hage J.E.
        • Schoch P.E.
        • et al.
        Unnecessary repeat Clostridium difficile PCR testing in hospitalized adults with C. difficile-negative diarrhea.
        Eur J Clin Microbiol Infect Dis. 2012; 32: 97-99
        • D'Agostino Sr., R.B.
        • Collins S.H.
        • Pencina K.M.
        • et al.
        Risk estimation for recurrent Clostridium difficile infection based on clinical factors.
        Clin Infect Dis. 2014; 58: 1386-1393
        • Leav B.A.
        • Blair B.
        • Leney M.
        • et al.
        Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI).
        Vaccine. 2009; 28: 965-969
        • Chang T.W.
        • Lin P.S.
        • Gorbach S.L.
        • et al.
        Ultrastructural changes of cultured human amnion cells by Clostridium difficile toxin.
        Infect Immun. 1979; 23: 795-798
        • Lyerly D.M.
        • Krivan H.C.
        • Wilkins T.D.
        Clostridium difficile: its disease and toxins.
        Clin Microbiol Rev. 1988; 1: 1-18
        • George W.L.
        • Sutter V.L.
        • Citron D.
        • et al.
        Selective and differential medium for isolation of Clostridium difficile.
        J Clin Microbiol. 1979; 9: 214-219
        • Lister M.
        • Stevenson E.
        • Heeg D.
        • et al.
        Comparison of culture based methods for the isolation of Clostridium difficile from stool samples in a research setting.
        Anaerobe. 2014; 28: 226-229
        • Lyras D.
        • O'Connor J.R.
        • Howarth P.M.
        • et al.
        Toxin B is essential for virulence of Clostridium difficile.
        Nature. 2009; 458: 1176-1179
        • Kuehne S.A.
        • Cartman S.T.
        • Heap J.T.
        • et al.
        The role of toxin A and toxin B in Clostridium difficile infection.
        Nature. 2010; 467: 711-713
        • Ticehurst J.R.
        • Aird D.Z.
        • Dam L.M.
        • et al.
        Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin.
        J Clin Microbiol. 2006; 44: 1145-1149
        • Gilligan P.H.
        Is a two-step glutamate dehyrogenase antigen-cytotoxicity neutralization assay algorithm superior to the premier toxin A and B enzyme immunoassay for laboratory detection of Clostridium difficile?.
        J Clin Microbiol. 2008; 46: 1523-1525
        • Fenner L.
        • Widmer A.F.
        • Goy G.
        • et al.
        Rapid and reliable diagnostic algorithm for detection of Clostridium difficile.
        J Clin Microbiol. 2008; 46: 328-330
        • Quinn C.D.
        • Sefers S.E.
        • Babiker W.
        • et al.
        C. Diff Quik Chek complete enzyme immunoassay provides a reliable first-line method for detection of Clostridium difficile in stool specimens.
        J Clin Microbiol. 2009; 48: 603-605
        • Sharp S.E.
        • Ruden L.O.
        • Pohl J.C.
        • et al.
        Evaluation of the C. Diff Quik Chek Complete Assay, a new glutamate dehydrogenase and A/B toxin combination lateral flow assay for use in rapid, simple diagnosis of Clostridium difficile disease.
        J Clin Microbiol. 2010; 48: 2082-2086
        • O'Horo J.C.
        • Jones A.
        • Sternke M.
        • et al.
        Molecular techniques for diagnosis of Clostridium difficile infection: systematic review and meta-analysis.
        Mayo Clin Proc. 2012; 87: 643-651
        • Deshpande A.
        • Pasupuleti V.
        • Rolston D.D.
        • et al.
        Diagnostic accuracy of real-time polymerase chain reaction in detection of Clostridium difficile in the stool samples of patients with suspected Clostridium difficile infection: a meta-analysis.
        Clin Infect Dis. 2011; 53: e81-e90
      1. College of American Pathologists. D-A Bacteriology participant survey. Northfield (IL): American College of Pathologists; 2014.

        • Culbreath K.
        • Ager E.
        • Nemeyer R.J.
        • et al.
        Evolution of testing algorithms at a university hospital for detection of Clostridium difficile infections.
        J Clin Microbiol. 2012; 50: 3073-3076
        • Khare R.
        • Espy M.J.
        • Cebelinski E.
        • et al.
        Comparative evaluation of two commercial multiplex panels for detection of gastrointestinal pathogens by use of clinical stool specimens.
        J Clin Microbiol. 2014; 52: 3667-3673
        • Planche T.D.
        • Davies K.A.
        • Coen P.G.
        • et al.
        Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection.
        Lancet Infect Dis. 2013; 13: 936-945
        • Beaulieu C.
        • Dionne L.L.
        • Julien A.S.
        • et al.
        Clinical characteristics and outcome of patients with Clostridium difficile infection diagnosed by PCR versus a three-step algorithm.
        Clin Microbiol Infect. 2014; 20: 1067-1073
        • Landry M.L.
        • Ferguson D.
        • Topal J.
        Comparison of Simplexa universal direct PCR with cytotoxicity assay for diagnosis of Clostridium difficile infection: performance, cost, and correlation with disease.
        J Clin Microbiol. 2014; 52: 275-280
        • Baker I.
        • Leeming J.P.
        • Reynolds R.
        • et al.
        Clinical relevance of a positive molecular test in the diagnosis of Clostridium difficile infection.
        J Hosp Infect. 2013; 84: 311-315
        • Leslie J.L.
        • Cohen S.H.
        • Solnick J.V.
        • et al.
        Role of fecal Clostridium difficile load in discrepancies between toxin tests and PCR: is quantitation the next step in C. difficile testing?.
        Eur J Clin Microbiol Infect Dis. 2012; 31: 3295-3299
        • Polage C.R.
        • Chin D.L.
        • Leslie J.L.
        • et al.
        Outcomes in patients tested for Clostridium difficile toxins.
        Diagn Microbiol Infect Dis. 2012; 74: 369-373
        • Beck E.T.
        • Buchan B.W.
        • Riebe K.M.
        • et al.
        Multicenter evaluation of the Quidel Lyra Direct C. difficile nucleic acid amplification assay.
        J Clin Microbiol. 2014; 52: 1998-2002
        • Barbut F.
        • Surgers L.
        • Eckert C.
        • et al.
        Does a rapid diagnosis of Clostridium difficile infection impact on quality of patient management?.
        Clin Microbiol Infect. 2013; 20: 136-144
        • Sydnor E.R.
        • Lenhart A.
        • Trollinger B.
        • et al.
        Antimicrobial prescribing practices in response to different Clostridium difficile diagnostic methodologies.
        Infect Control Hosp Epidemiol. 2011; 32: 1133-1136
        • Gould C.V.
        • Edwards J.R.
        • Cohen J.
        • et al.
        Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection.
        Clin Infect Dis. 2013; 57: 1304-1307
        • Williamson D.A.
        • Basu I.
        • Freeman J.
        • et al.
        Improved detection of toxigenic Clostridium difficile using the Cepheid Xpert C difficile assay and impact on C difficile infection rates in a tertiary hospital: a double-edged sword.
        Am J Infect Control. 2012; 41: 270-272
        • Longtin Y.
        • Trottier S.
        • Brochu G.
        • et al.
        Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program.
        Clin Infect Dis. 2013; 56: 67-73